Premium
Validity and Reliability of Patient‐Reported Outcomes Measurement Information System Instruments in Osteoarthritis
Author(s) -
Broderick Joan E.,
Schneider Stefan,
Junghaenel Doerte U.,
Schwartz Joseph E.,
Stone Arthur A.
Publication year - 2013
Publication title -
arthritis care and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.032
H-Index - 163
eISSN - 2151-4658
pISSN - 2151-464X
DOI - 10.1002/acr.22025
Subject(s) - computerized adaptive testing , reliability (semiconductor) , physical therapy , osteoarthritis , population , medicine , concurrent validity , fibromyalgia , clinical psychology , psychology , psychometrics , pathology , environmental health , power (physics) , physics , alternative medicine , quantum mechanics , internal consistency
Objective Evaluation of known‐group validity, ecological validity, and test–retest reliability of 4 domain instruments from the Patient‐Reported Outcomes Measurement Information System (PROMIS) in osteoarthritis (OA) patients. Methods We recruited an OA sample and a comparison general population (GP) sample through an internet survey panel. Pain intensity, pain interference, physical functioning, and fatigue were assessed for 4 consecutive weeks with PROMIS short forms on a daily basis and compared with same‐domain Computer Adaptive Testing (CAT) instruments that use a 7‐day recall. Known‐group validity (comparison of OA and GP), ecological validity (comparison of aggregated daily measures with CAT instruments), and test–retest reliability were evaluated. Results The recruited samples matched the demographic characteristics (age, sex, race, and ethnicity) of the US sample for arthritis and the 2009 Census for the GP. Compliance with repeated measurements was excellent at >95%. Known‐group validity for CATs was demonstrated with large effect sizes (pain intensity 1.42, pain interference 1.25, and fatigue 0.85). Ecological validity was also established through high correlations between aggregated daily measures and weekly CATs (≥0.86). Test–retest validity (7‐day) was very good (≥0.80). Conclusion PROMIS CAT instruments demonstrated known‐group and ecological validity in a comparison of OA patients with a GP sample. Adequate test–retest reliability was also observed. These data provide encouraging initial data on the utility of these PROMIS instruments for clinical and research outcomes in OA patients.